购物车
- 全部删除
- 您的购物车当前为空
STAT3-IN-31 (compound K2071),一种基于STATtic开发的STAT3和有丝分裂抑制剂,具备阻断有丝分裂进展及干扰纺锤体形成的功能。此外,它能够抑制胶质母细胞瘤细胞的迁移和肿瘤球体中细胞的增殖,诱导细胞衰老,并抑制抗Temozolomide的胶质母细胞瘤细胞生长,以及单核细胞趋化蛋白MCP-1的分泌,从而阻止炎症反应。
STAT3-IN-31 (compound K2071),一种基于STATtic开发的STAT3和有丝分裂抑制剂,具备阻断有丝分裂进展及干扰纺锤体形成的功能。此外,它能够抑制胶质母细胞瘤细胞的迁移和肿瘤球体中细胞的增殖,诱导细胞衰老,并抑制抗Temozolomide的胶质母细胞瘤细胞生长,以及单核细胞趋化蛋白MCP-1的分泌,从而阻止炎症反应。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | STAT3-IN-31 (compound K2071), derived from STATtic, acts as an inhibitor of both STAT3 and mitotic processes. This compound interrupts mitotic progression and impacts the formation of the mitotic spindle. Additionally, STAT3-IN-31 hampers migration in glioblastoma cells, suppresses cellular proliferation within tumor spheroids, induces senescence in glioblastoma, and inhibits the growth of Temozolomide-resistant cells while reducing the secretion of the pro-inflammatory cytokine monocyte chemoattractant protein (MCP-1). |
分子量 | 301.36 |
分子式 | C16H15NO3S |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容